Cargando…
Remission of ulcerative colitis flare-up induced by nivolumab
BACKGROUND: Immune checkpoint inhibitors (ICIs) have been used to treat many cancers, but ICIs are rarely administered for malignant tumours coexisting with inflammatory bowel disease. METHODS AND RESULTS: We report a 77-year-old man experiencing an ulcerative colitis (UC) flare-up after receiving n...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Berlin Heidelberg
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7415029/ https://www.ncbi.nlm.nih.gov/pubmed/32458394 http://dx.doi.org/10.1007/s00384-020-03638-3 |